WELLINGTON MANAGEMENT GROUP LLP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$255,143,765
-18.0%
5,080,521
+3.2%
0.05%
-13.6%
Q2 2023$311,178,725
+34.6%
4,923,714
-4.2%
0.06%
+28.3%
Q1 2023$231,145,257
+5.4%
5,137,703
+2.7%
0.05%
+4.5%
Q4 2022$219,200,182
-13.0%
5,003,428
+30.8%
0.04%
-18.5%
Q3 2022$251,962,000
+99.6%
3,823,979
+53.0%
0.05%
+116.0%
Q2 2022$126,257,000
-49.4%
2,499,674
-36.1%
0.02%
-41.9%
Q1 2022$249,703,000
-33.0%
3,908,944
+12.4%
0.04%
-28.3%
Q4 2021$372,457,000
+13.2%
3,477,325
+8.7%
0.06%
+7.1%
Q3 2021$328,893,000
+85.5%
3,199,041
+58.7%
0.06%
+86.7%
Q2 2021$177,333,000
+36.6%
2,016,062
+51.0%
0.03%
+30.4%
Q1 2021$129,829,000
+11.7%
1,335,277
+28.8%
0.02%
+9.5%
Q4 2020$116,259,000
+29.1%
1,036,630
+6.7%
0.02%
+10.5%
Q3 2020$90,074,000
-14.3%
971,667
-27.9%
0.02%
-17.4%
Q2 2020$105,136,000
+19.8%
1,347,903
-10.2%
0.02%0.0%
Q1 2020$87,748,000
-55.6%
1,500,462
-39.2%
0.02%
-43.9%
Q4 2019$197,659,000
+7.7%
2,467,327
-1.2%
0.04%0.0%
Q3 2019$183,532,000
-29.0%
2,498,045
-8.9%
0.04%
-28.1%
Q2 2019$258,675,000
+27.3%
2,742,241
+8.1%
0.06%
+23.9%
Q1 2019$203,122,000
+43.2%
2,537,439
-3.6%
0.05%
+27.8%
Q4 2018$141,883,000
-38.2%
2,631,859
-10.5%
0.04%
-25.0%
Q3 2018$229,615,000
+33.9%
2,941,517
+8.9%
0.05%
+26.3%
Q2 2018$171,422,000
-30.1%
2,700,399
+0.9%
0.04%
-32.1%
Q1 2018$245,403,000
+31.8%
2,676,150
+8.4%
0.06%
+36.6%
Q4 2017$186,140,000
-16.7%
2,468,375
-23.0%
0.04%
-19.6%
Q3 2017$223,415,000
+41.8%
3,206,772
+3.1%
0.05%
+37.8%
Q2 2017$157,567,000
+3.1%
3,109,697
-18.6%
0.04%0.0%
Q1 2017$152,826,000
+328.3%
3,821,584
+200.4%
0.04%
+311.1%
Q4 2016$35,678,000
+7.0%
1,271,961
+13.3%
0.01%
+12.5%
Q3 2016$33,329,000
+43.2%
1,122,216
-2.3%
0.01%
+33.3%
Q2 2016$23,270,000
+140.3%
1,149,078
+114.2%
0.01%
+100.0%
Q1 2016$9,682,000
-22.3%
536,416
+13.4%
0.00%0.0%
Q4 2015$12,459,000
-53.9%
473,001
-62.6%
0.00%
-62.5%
Q3 2015$26,999,000
-10.1%
1,265,173
+10.9%
0.01%0.0%
Q2 2015$30,034,0001,140,8780.01%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders